Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ascorbic acid, cell proliferation, and cancer.

Literature DB >> 4110043

Ascorbic acid, cell proliferation, and cancer.

E Cameron, D Rotman.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1972 PMID： 4110043 DOI： 10.1016/s0140-6736(72)90215-2

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

22 in total

1. The X_c^- inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism.

Authors: Zijie Zheng; Ganhua Luo; Xinchong Shi; Yali Long; Wanqing Shen; Zhoulei Li; Xiangsong Zhang
Journal: Cell Oncol (Dordr) Date: 2019-10-15 Impact factor: 6.730

2. O₂^⋅- and H₂O₂-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

Authors: Joshua D Schoenfeld; Zita A Sibenaller; Kranti A Mapuskar; Brett A Wagner; Kimberly L Cramer-Morales; Muhammad Furqan; Sonia Sandhu; Thomas L Carlisle; Mark C Smith; Taher Abu Hejleh; Daniel J Berg; Jun Zhang; John Keech; Kalpaj R Parekh; Sudershan Bhatia; Varun Monga; Kellie L Bodeker; Logan Ahmann; Sandy Vollstedt; Heather Brown; Erin P Shanahan Kauffman; Mary E Schall; Ray J Hohl; Gerald H Clamon; Jeremy D Greenlee; Matthew A Howard; Michael K Schultz; Brian J Smith; Dennis P Riley; Frederick E Domann; Joseph J Cullen; Garry R Buettner; John M Buatti; Douglas R Spitz; Bryan G Allen
Journal: Cancer Cell Date: 2017-08-14 Impact factor: 31.743

3. In vitro and in vivo assessment of high-dose vitamin C against murine tumors.

Authors: Guoping Wang; Tao Yin; Yongsheng Wang
Journal: Exp Ther Med Date: 2016-09-16 Impact factor: 2.447

Review 4. Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.

Authors: Nermi L Parrow; Jonathan A Leshin; Mark Levine
Journal: Antioxid Redox Signal Date: 2013-06-19 Impact factor: 8.401

5. Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance.

Authors: Joseph J Cullen; Douglas R Spitz; Garry R Buettner
Journal: Free Radic Biol Med Date: 2011-04-01 Impact factor: 7.376

Ascorbic acid, cell proliferation, and cancer.

1. The X_c^- inhibitor sulfasalazine improves the anti-cancer effect of pharmacological vitamin C in prostate cancer cells via a glutathione-dependent mechanism.

2. O₂^⋅- and H₂O₂-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

3. In vitro and in vivo assessment of high-dose vitamin C against murine tumors.

Review 4. Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.

5. Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance.

Review 6. Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.

7. The prospects of vitamin C in cancer therapy.

8. Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.

9. Inhibition of benzo(a)pyrene carcinogenesis in rats with vitamin C.

10. Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer.